Based on existing literature, the potential mechanism, clinical characteristics, and treatment of COVID-19-associated arthritis is discussed.
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
The newly redesigned Rheumatology Advisor offers its readers improved access to timely and quality clinical content.
The EULAR released points-to-consider to improve and support work participation among patients with rheumatic and musculoskeletal diseases.
HIPAA protects patients from unauthorized disclosure of personal information by covered entities such as medical practices and hospitals, but out from under the HIPAA umbrella, patients are mostly on their own, according to the authors of a recent report.
Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.
Ethics consultants begin by identifying and clarifying the conflict to ensure it is related to ethics.
Expert provides strategies for advocating for APRN full practice authority by presenting the health equity case and business case.
Looking at stress and university students during the COVID-19 pandemic.
Rheumatologists, Joshua Baker, MD, Brian Andonian, MD, and Ira Khanna, MD, discuss the occurrence and management of muscle weakness and loss among patients with rheumatoid arthritis.